[Therapy conversion to cilazapril in angiotensin conversion enzyme inhibitor-induced cough. Evaluation of the effect].
Cardiovascular Research Foundation, Bad Schwalbach, BRD.
A
A
Schneeweiss
D000328:Adult; D000368:Aged; D002216:Captopril / Q000009:adverse effects* / Q000627:therapeutic use; D017315:Cilazapril / Q000009:adverse effects / Q000627:therapeutic use*; D003371:Cough / Q000139:chemically induced*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004656:Enalapril / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D017315:Cilazapril; D004656:Enalapril; D002216:Captopril
Therapieumstellung auf Cilazapril bei Angiotensin-Konversionsenzym-Hemmer-induziertem Husten. Beurteilung des Effekts.